XAIR

Beyond Cancer: Israeli Ministry of Health Approved Use of Low Volume Uno in Phase 1B Clinical Trial of Lv Uno in Combination With Anti-Pd-1 Therapy

时间:2024-12-04 06:29:04 市场: 美股 综合

关联: XAIR

Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1B Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (Lv Uno) in Combination With Anti-Pd-1 Therapy

时间:2024-12-04 05:14:11 市场: 美股 综合

关联: XAIR

Beyond Air Receives Ce Mark in Europe for the Lungfit® Ph System

时间:2024-12-02 20:34:47 市场: 美股 综合

关联: XAIR

Avenue Capital Management Ii, L.p. Reports 14.7% Passive Stake in Beyond Air Inc as of September 26 - SEC Filing

时间:2024-10-04 03:13:51 市场: 美股 综合

关联: XAIR

Beyond Air: Entered Into Binding Term Sheet for Secured Loan With Some Lenders Including CEO Steven Lisi, Director Robert Carey

时间:2024-10-03 05:03:31 市场: 综合 美股

关联: XAIR

Beyond Air: Term Sheet Provides for Principal Amount of $11.5 Mln

时间:2024-10-03 05:03:31 市场: 美股 综合

关联: XAIR

Beyond Air Partners With Healthcare Links to Expand Access to Lungfit® Ph System Through Group Purchasing Organizations and Integrated Delivery Networks

时间:2024-10-02 19:31:55 市场: 综合 美股

关联: XAIR

Beyond Air Provides Lungfit® Ph System to U.S. Naval Hospital Guam for Neonatal Critical Care in Partnership With Trillamed

时间:2024-09-27 19:34:00 市场: 美股 综合

关联: XAIR

Beyond Air Announces Termination of the Loan and Security Agreements With Avenue Capital

时间:2024-09-27 19:32:00 市场: 综合 美股

关联: XAIR

Beyond Air Announces $20.6 Million Private Placement Offering Priced at-the-Market Under Nasdaq Rules

时间:2024-09-27 19:30:00 市场: 美股 综合

关联: XAIR